Copyright Reports & Markets. All rights reserved.

Global Deep Brain Stimulation in Parkinson's Disease Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Market Analysis by Type
    • 1.3.1 Global Deep Brain Stimulation in Parkinson's Disease Market Size Growth Rate by Type: 2020 VS 2026
    • 1.3.2 Dual Channel Deep brain Stimulator
    • 1.3.3 Single Channel Deep brain Stimulator
  • 1.4 Market by Application
    • 1.4.1 Global Deep Brain Stimulation in Parkinson's Disease Market Share by Application: 2020 VS 2026
    • 1.4.2 Hospitals
    • 1.4.3 Neurology Clinics
    • 1.4.4 Research Centers
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Deep Brain Stimulation in Parkinson's Disease Market Perspective (2015-2026)
  • 2.2 Deep Brain Stimulation in Parkinson's Disease Growth Trends by Regions
    • 2.2.1 Deep Brain Stimulation in Parkinson's Disease Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Deep Brain Stimulation in Parkinson's Disease Historic Market Share by Regions (2015-2020)
    • 2.2.3 Deep Brain Stimulation in Parkinson's Disease Forecasted Market Size by Regions (2021-2026)
  • 2.3 Deep Brain Stimulation in Parkinson's Disease Industry Dynamic
    • 2.3.1 Deep Brain Stimulation in Parkinson's Disease Market Trends
    • 2.3.2 Deep Brain Stimulation in Parkinson's Disease Market Drivers
    • 2.3.3 Deep Brain Stimulation in Parkinson's Disease Market Challenges
    • 2.3.4 Deep Brain Stimulation in Parkinson's Disease Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Deep Brain Stimulation in Parkinson's Disease Players by Market Size
    • 3.1.1 Global Top Deep Brain Stimulation in Parkinson's Disease Players by Revenue (2015-2020)
    • 3.1.2 Global Deep Brain Stimulation in Parkinson's Disease Revenue Market Share by Players (2015-2020)
  • 3.2 Global Deep Brain Stimulation in Parkinson's Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Deep Brain Stimulation in Parkinson's Disease Revenue
  • 3.4 Global Deep Brain Stimulation in Parkinson's Disease Market Concentration Ratio
    • 3.4.1 Global Deep Brain Stimulation in Parkinson's Disease Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Deep Brain Stimulation in Parkinson's Disease Revenue in 2019
  • 3.5 Key Players Deep Brain Stimulation in Parkinson's Disease Area Served
  • 3.6 Key Players Deep Brain Stimulation in Parkinson's Disease Product Solution and Service
  • 3.7 Date of Enter into Deep Brain Stimulation in Parkinson's Disease Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Deep Brain Stimulation in Parkinson's Disease Breakdown Data by Type

  • 4.1 Global Deep Brain Stimulation in Parkinson's Disease Historic Market Size by Type (2015-2020)
  • 4.2 Global Deep Brain Stimulation in Parkinson's Disease Forecasted Market Size by Type (2021-2026)

5 Deep Brain Stimulation in Parkinson's Disease Breakdown Data by Application

  • 5.1 Global Deep Brain Stimulation in Parkinson's Disease Historic Market Size by Application (2015-2020)
  • 5.2 Global Deep Brain Stimulation in Parkinson's Disease Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Deep Brain Stimulation in Parkinson's Disease Market Size (2015-2026)
  • 6.2 North America Deep Brain Stimulation in Parkinson's Disease Market Size by Type (2015-2020)
  • 6.3 North America Deep Brain Stimulation in Parkinson's Disease Market Size by Application (2015-2020)
  • 6.4 North America Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Deep Brain Stimulation in Parkinson's Disease Market Size (2015-2026)
  • 7.2 Europe Deep Brain Stimulation in Parkinson's Disease Market Size by Type (2015-2020)
  • 7.3 Europe Deep Brain Stimulation in Parkinson's Disease Market Size by Application (2015-2020)
  • 7.4 Europe Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Size (2015-2026)
  • 8.2 Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Size by Type (2015-2020)
  • 8.3 Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Size by Application (2015-2020)
  • 8.4 Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia

9 Latin America

  • 9.1 Latin America Deep Brain Stimulation in Parkinson's Disease Market Size (2015-2026)
  • 9.2 Latin America Deep Brain Stimulation in Parkinson's Disease Market Size by Type (2015-2020)
  • 9.3 Latin America Deep Brain Stimulation in Parkinson's Disease Market Size by Application (2015-2020)
  • 9.4 Latin America Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Size (2015-2026)
  • 10.2 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Size by Type (2015-2020)
  • 10.3 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Size by Application (2015-2020)
  • 10.4 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE

11Key Players Profiles

  • 11.1 Abbott
    • 11.1.1 Abbott Company Details
    • 11.1.2 Abbott Business Overview
    • 11.1.3 Abbott Deep Brain Stimulation in Parkinson's Disease Introduction
    • 11.1.4 Abbott Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2015-2020))
    • 11.1.5 Abbott Recent Development
  • 11.2 Aleva Neurotherapeutics SA
    • 11.2.1 Aleva Neurotherapeutics SA Company Details
    • 11.2.2 Aleva Neurotherapeutics SA Business Overview
    • 11.2.3 Aleva Neurotherapeutics SA Deep Brain Stimulation in Parkinson's Disease Introduction
    • 11.2.4 Aleva Neurotherapeutics SA Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2015-2020)
    • 11.2.5 Aleva Neurotherapeutics SA Recent Development
  • 11.3 Beijing PINS Medical Co
    • 11.3.1 Beijing PINS Medical Co Company Details
    • 11.3.2 Beijing PINS Medical Co Business Overview
    • 11.3.3 Beijing PINS Medical Co Deep Brain Stimulation in Parkinson's Disease Introduction
    • 11.3.4 Beijing PINS Medical Co Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2015-2020)
    • 11.3.5 Beijing PINS Medical Co Recent Development
  • 11.4 Boston Scientific Corporation
    • 11.4.1 Boston Scientific Corporation Company Details
    • 11.4.2 Boston Scientific Corporation Business Overview
    • 11.4.3 Boston Scientific Corporation Deep Brain Stimulation in Parkinson's Disease Introduction
    • 11.4.4 Boston Scientific Corporation Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2015-2020)
    • 11.4.5 Boston Scientific Corporation Recent Development
  • 11.5 Functional Neuromodulation Ltd
    • 11.5.1 Functional Neuromodulation Ltd Company Details
    • 11.5.2 Functional Neuromodulation Ltd Business Overview
    • 11.5.3 Functional Neuromodulation Ltd Deep Brain Stimulation in Parkinson's Disease Introduction
    • 11.5.4 Functional Neuromodulation Ltd Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2015-2020)
    • 11.5.5 Functional Neuromodulation Ltd Recent Development
  • 11.6 Medtronic
    • 11.6.1 Medtronic Company Details
    • 11.6.2 Medtronic Business Overview
    • 11.6.3 Medtronic Deep Brain Stimulation in Parkinson's Disease Introduction
    • 11.6.4 Medtronic Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2015-2020)
    • 11.6.5 Medtronic Recent Development
  • 11.7 Neuronetics Inc.
    • 11.7.1 Neuronetics Inc. Company Details
    • 11.7.2 Neuronetics Inc. Business Overview
    • 11.7.3 Neuronetics Inc. Deep Brain Stimulation in Parkinson's Disease Introduction
    • 11.7.4 Neuronetics Inc. Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2015-2020)
    • 11.7.5 Neuronetics Inc. Recent Development
  • 11.8 NeuroPace Inc.
    • 11.8.1 NeuroPace Inc. Company Details
    • 11.8.2 NeuroPace Inc. Business Overview
    • 11.8.3 NeuroPace Inc. Deep Brain Stimulation in Parkinson's Disease Introduction
    • 11.8.4 NeuroPace Inc. Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2015-2020)
    • 11.8.5 NeuroPace Inc. Recent Development
  • 11.9 Nevro Corporation
    • 11.9.1 Nevro Corporation Company Details
    • 11.9.2 Nevro Corporation Business Overview
    • 11.9.3 Nevro Corporation Deep Brain Stimulation in Parkinson's Disease Introduction
    • 11.9.4 Nevro Corporation Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2015-2020)
    • 11.9.5 Nevro Corporation Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Deep Brain Stimulation in Parkinson's Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Deep Brain Stimulation in Parkinson's Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Dual Channel Deep brain Stimulator
    Single Channel Deep brain Stimulator

    Market segment by Application, split into
    Hospitals
    Neurology Clinics
    Research Centers

    Based on regional and country-level analysis, the Deep Brain Stimulation in Parkinson's Disease market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    In the competitive analysis section of the report, leading as well as prominent players of the global Deep Brain Stimulation in Parkinson's Disease market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Abbott
    Aleva Neurotherapeutics SA
    Beijing PINS Medical Co
    Boston Scientific Corporation
    Functional Neuromodulation Ltd
    Medtronic
    Neuronetics Inc.
    NeuroPace Inc.

    Buy now